These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Genetic predisposition for breast cancer: BRCA1 and BRCA2 genes]. Narod SA, Rodríguez AA. Salud Publica Mex; 2011; 53(5):420-9. PubMed ID: 22218796 [Abstract] [Full Text] [Related]
6. Italian family with two independent mutations: 3358T/A in BRCA1 and 8756delA in BRCA2 genes. Cortesi L, Turchetti D, Bertoni C, Zanocco-Marani T, Vinceti M, Silvestri C, Federico M, Silingardi V, Ferrari S. Eur J Hum Genet; 2003 Mar; 11(3):210-4. PubMed ID: 12673274 [Abstract] [Full Text] [Related]
9. Hereditary breast cancer: high risk genes, genetic testing and clinical implications. Hamann U. Clin Lab; 2000 Mar; 46(9-10):447-61. PubMed ID: 11034530 [Abstract] [Full Text] [Related]
10. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Fackenthal JD, Olopade OI. Nat Rev Cancer; 2007 Dec; 7(12):937-48. PubMed ID: 18034184 [Abstract] [Full Text] [Related]
14. Sex ratio distortion in offspring of families with BRCA1 or BRCA2 mutant alleles: an ascertainment bias phenomenon? Balmaña J, Díez O, Campos B, Majewski M, Sanz J, Alonso C, Baiget M, Garber JE. Breast Cancer Res Treat; 2005 Aug; 92(3):273-7. PubMed ID: 16155798 [Abstract] [Full Text] [Related]
15. Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families. García MJ, Fernández V, Osorio A, Barroso A, Llort G, Lázaro C, Blanco I, Caldés T, de la Hoya M, Ramón Y Cajal T, Alonso C, Tejada MI, San Román C, Robles-Díaz L, Urioste M, Benítez J. Breast Cancer Res Treat; 2009 Feb; 113(3):545-51. PubMed ID: 18302019 [Abstract] [Full Text] [Related]
16. Hereditary breast cancer syndromes and clinical implications. Majdak-Paredes EJ, Fatah F. J Plast Reconstr Aesthet Surg; 2009 Feb; 62(2):181-9. PubMed ID: 19027378 [Abstract] [Full Text] [Related]
17. Cancer risk assessment and the genetic counseling process: using hereditary breast and ovarian cancer as an example. Prucka SK, McIlvried DE, Korf BR. Med Princ Pract; 2008 Feb; 17(3):173-89. PubMed ID: 18408385 [Abstract] [Full Text] [Related]
20. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers. Walker LC, Waddell N, Ten Haaf A, kConFab Investigators, Grimmond S, Spurdle AB. Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154 [Abstract] [Full Text] [Related] Page: [Next] [New Search]